Amphastar Pharmaceuticals (AMPH) P/E (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) P/E from Jun 25, 2014 to Jun 3, 2026. The TTM Amphastar Pharmaceuticals (AMPH) P/E is 10.53. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Amphastar Pharmaceuticals (AMPH)
| Year | P/E | Change |
|---|---|---|
| 2026 | 10.53 | -17.13% |
| 2025 | 12.71 | +12.67% |
| 2024 | 11.28 | -48.80% |
| 2023 | 22.03 | +25.17% |
| 2022 | 17.60 | -1.95% |
| 2021 | 17.95 | -97.17% |
| 2020 | 633.27 | +3301.85% |
| 2019 | 18.62 | -111.48% |
| 2018 | -162.10 | -91.19% |
| 2017 | -1.84K | -4690.00% |
| 2016 | 40.09 | -117.31% |
| 2015 | -231.51 | +388.89% |
| 2014 | -47.35 | N/A |
Comparison Amphastar Pharmaceuticals (AMPH) P/E with competitors
Amphastar Pharmaceuticals (AMPH) P/E is 10.53.